The γ-ray strength function and level density in the quasi-continuum of 151,153 Sm have been measured using BGO shielded Ge clover detectors of the STARLiTeR system. The Compton shields allow for an extraction of the γ strength down to unprecedentedly low γ energies of ≈ 500 keV. For the first time an enhanced lowenergy γ-ray strength has been observed in the rare-earth region. In addition, for the first time both the upbend and the well known scissors resonance have been observed simultaneously for the same nucleus. HauserFeshbach calculations show that this strength enhancement at low γ energies could have an impact of 2-3 orders of magnitude on the (n,γ) reaction rates for the r-process nucleosynthesis.
A gridded ionization chamber used as a focal plane detector at the back of the TAMU-MDM spectrometer was modified to use MicroMegas technology for the purpose of improving energy resolution and particle identification. The upgraded system was tested in experimental conditions with several heavy-ion beams at 12 MeV/u and found to achieve resolutions between 3.2% and 4.8%. This is a significant improvement over the previous performance of 10-15% obtained using the existing, conventional ionization chambers.
Hyperion is a new high-efficiency charged-particle γ-ray detector array which consists of a segmented silicon telescope for charged-particle detection and up to fourteen high-purity germanium clover detectors for the detection of coincident γ rays. The array will be used in nuclear physics measurements and Stockpile Stewardship studies and replaces the STARLiTeR array. This article discusses the features of the array and presents data collected with the array in the commissioning experiment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.